The team at PTEN Research

Tom joined the Foundation in 2019 as Director of Clinical Development. In Spring of 2021 he was appointed Chief Executive of the Foundation, a new role reflecting the growth of activity since the Foundation was formed in 2017. 

In addition to overseeing the overall strategy and deliverables of the Foundation, Tom also oversees the Foundation's Clinical Development activities, partnering with academic investigators and industry collaborators to support the Foundation’s mission.

Tom has over 25 years of drug development experience gained from both the big pharma and the biotech sector. He has an extensive background in exploratory drug development in a range of therapeutic areas with a focus on oncology and cancer immunotherapy. Before joining PTEN research, Tom supported the development and growth of the European team as a Director of Clinical Operations for a Boston based biopharmaceutical company with a focus on rare diseases.

Ask me about: The activities of the Foundation and strategy including clinical development, investigator sponsored trials/clinical collaborations, patient data and natural history studies.